dihydroalprenolol has been researched along with quipazine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koch, SW; Koe, BK; Lebel, LA; Minor, KW; Page, MG | 1 |
| Eison, AS; Gianutsos, G; Yocca, FD | 1 |
2 other study(ies) available for dihydroalprenolol and quipazine
| Article | Year |
|---|---|
Sertraline, a selective inhibitor of serotonin uptake, induces subsensitivity of beta-adrenoceptor system of rat brain.
Topics: 1-Naphthylamine; Adenylyl Cyclases; Animals; Brain; Dihydroalprenolol; Male; Naphthalenes; Quipazine; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Adrenergic, beta; Serotonin Antagonists; Sertraline | 1987 |
Noradrenergic denervation alters serotonin2-mediated behavior but not serotonin2 receptor number in rats: modulatory role of beta adrenergic receptors.
Topics: Animals; Behavior, Animal; Benzylamines; Clenbuterol; Dihydroalprenolol; Drug Interactions; Injections, Subcutaneous; Male; Neurotransmitter Agents; Norepinephrine; Propranolol; Quipazine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Receptors, Serotonin; Serotonin Antagonists | 1988 |